Cancer Survivorship and Care / Oral Health in Cancer Treatment · Journal article
Indian Journal of Palliative Care · September 8, 2026
Encouraging direction, but not yet definitive.
This is a single-centre, open-label RCT demonstrating that a multicomponent self-help intervention significantly reduces fatigue and improves functional performance, quality of life, and aerobic capacity in patients undergoing chemotherapy, compared to standard care. The results are statistically robust but limited by open design, lack of blinding, and absence of hard clinical outcomes or long-term follow-up beyond 12 weeks.
Prospective, open, randomised parallel-group trial. Patients with cancer admitted for the second cycle of chemotherapy who fulfilled unspecified eligibility criteria.. Intervention: Multicomponent self-help intervention package (MSHIP) targeting fatigue; specific components not detailed in source.. Compared with: Control group (standard care; details not specified)..
Fatigue scores showed substantial difference between MSHIP and control groups (F = 86.45, p < 0.001) Functional performance scores differed significantly (F = 27.95, p < 0.001) Quality of life scores showed significant improvement (F = 13.19, p < 0.001)
Outcomes are surrogate measures (symptom scales, functional tests); no hard clinical endpoints (mortality, recurrence, hospitalisation) reported. Follow-up limited to 12 weeks; no data on durability, safety, or sustained benefit beyond this period.
Clinicians may consider incorporating multicomponent self-help interventions into routine oncology practice for chemotherapy-induced fatigue management, though the open design and lack of blinding warrant cautious interpretation. Replication in blinded, multi-centre trials is needed before widespread adoption.
A single-centre RCT with sound design (randomised, parallel-group) and statistically significant results on fatigue and functional outcomes in a moderately sized sample, but lacking hard clinical endpoints and with open design that limits generalisability.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians may consider incorporating multicomponent self-help interventions into routine oncology practice for chemotherapy-induced fatigue management, though the open design and lack of blinding warrant cautious interpretation. Replication in blinded, multi-centre trials is needed before widespread adoption.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Objectives: Fatigue ranks as a highly prevalent and distressing symptom stated by patients undergoing chemotherapy and/or radiation therapy. It significantly compromises the patients’ quality of life (QoL) and functional performance. The objective of this prospective trial was to evaluate the effectiveness of a multi-component self-help intervention package (MSHIP) targeting fatigue and improving functional performance, QoL and aerobic capacity of patients with cancer undergoing chemotherapy. Materials and Methods: A prospective, open, randomised parallel group trial with follow-up at 3, 6 and 12 weeks was adopted. Patients with cancer admitted for the second cycle of chemotherapy, who fulfilled eligibility criteria, enrolled in the study. Baseline data were collected, and participants were allocated into the MSHIP group and the control group with block randomisation. The outcomes were assessed by the Functional Assessment of Chronic Illness Therapy-Fatigue Scale, the Functional Assessment of Cancer Therapy-General Scale, and 6-min walk distance test. Results: The mean age was comparable between groups (experimental 49.17 ± 8.36 years vs. control 48.22 ± 9.21 years). A substantial difference in fatigue scores (F = 86.45, p < 0.001), functional performance scores (F = 27.95, p < 0.001), QoL scores (F = 13.19, p < 0.001) and aerobic capacity scores (F = 27.95, p < 0.001) between MSHIP group and control group was observed. Conclusion: MSHIP intervention empowers and enables patients with cancer undergoing chemotherapy for self-care activities for the management of fatigue and enhancing functional performance, QoL and aerobic capacity. This economic intervention has proved to be beneficial, and hence, it can be integrated into routine oncology clinical practice for its utilisation.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.